M 106 (Zidovudine 300 mg)
Pill with imprint M 106 is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Mylan Pharmaceuticals Inc..
Zidovudine is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure; reduction of perinatal transmission of hiv and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 106
Zidovudine
- Imprint
- M 106
- Strength
- 300 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6106
- Inactive Ingredients
-
magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato, titanium dioxide
Note: Inactive ingredients may vary.
Related Images for "M 106"
More about zidovudine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Zidovudine oral/injection
- Zidovudine (Advanced Reading)
- Zidovudine Intravenous (Advanced Reading)
- Zidovudine Capsules and Tablets
- Zidovudine Injection
- Zidovudine Syrup
Other brands: Retrovir
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
